Spots Global Cancer Trial Database for Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy
Official Title: A Randomized, Double-blind, Placebo Controlled, Dose Ranging Study to Evaluate the Efficacy and Safety of CDP6038 Administered Subcutaneously for 12 Weeks to Asian Subjects With Active Rheumatoid Arthritis Having Previously Failed TNF Blocker Therapy
Study ID: NCT01463059
Conditions
Study Description
Brief Summary: The primary objective of this study is to evaluate the efficacy and safety of CDP6038 administered subcutaneous (sc) at various doses compared to placebo.
Detailed Description:
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
102, Chiba, , Japan
114, Fukuoka, , Japan
115, Fukuoka, , Japan
113, Hiroshima, , Japan
120, Kakogawa, , Japan
118, Kumamoto, , Japan
116, Kurume, , Japan
121, Matsuyama, , Japan
122, Matsuyama, , Japan
107, Nagaoka, , Japan
110, Nagoya, , Japan
103, Narita, , Japan
119, Oita, , Japan
112, Okayama, , Japan
100, Sapporo, , Japan
117, Sasebo, , Japan
124, Tokorozawa, , Japan
123, Tokyo, , Japan
101, Tomakomai, , Japan
108, Tonami, , Japan
111, Tsu, , Japan
105, Yokohama, , Japan
104, Yotukaido, , Japan
200, Daejeon, , Korea, Republic of
201, Jung-gu, , Korea, Republic of
202, Seongdong-gu, , Korea, Republic of
203, Seoul, , Korea, Republic of
204, Seoul, , Korea, Republic of
303, Changhua, , Taiwan
304, Dalin-Town, , Taiwan
305, Hualien, , Taiwan
300, Kaohsiung, , Taiwan
301, Taichung, , Taiwan
306, Taichung, , Taiwan
307, Taichung, , Taiwan
302, Taipei, , Taiwan
308, Taipei, , Taiwan
309, Taipei, , Taiwan
310, Taipei, , Taiwan
Contact Details
Name: UCB Clinical Trial Call Center
Affiliation: +1 877 822 9493 (UCB)
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
